Checking CORT unusual options activity helps you spot when traders are making outsized bets on Corcept Therapeutics Inc before the broader market catches on. Corcept Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor CORT unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching CORT unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking CORT unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and CORT unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess.
The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.
Catalysts rarely arrive without a footprint, and CORT unusual options activity is often where that footprint shows up first. Our scanner tracks Corcept Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at CORT unusual options volume on the call side or chasing put sweeps, Corcept Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
